Patents by Inventor Paul G. Heyworth

Paul G. Heyworth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATION OF PILR RECEPTORS TO TREAT MICROBIAL INFECTIONS
    Publication number: 20140037627
    Abstract: The present invention provides methods of using agonists and antagonists of PILR? and PILR?, respectively, to treat S. aureus infection, in particular, S. aureus infections of the lungs. Also provided are use agonists and antagonists of PILR? and PILR?, respectively, to prevent such infections.
    Type: Application
    Filed: August 8, 2013
    Publication date: February 6, 2014
    Applicant: MERCK SHARP & DOHME CORP.
    Inventors: Antara Banerjee, Paul G. Heyworth
  • MODULATION OF PILR RECEPTORS TO TREAT SEPSIS
    Publication number: 20130323239
    Abstract: The present invention provides methods of using agonists and antagonists of PILR? and PILR?, respectively, to treat immune mediated sepsis. Also provided are methods of prophylactically treating with agonists and antagonists of PILR? and PILR?, respectively, to prevent the development of sepsis.
    Type: Application
    Filed: August 8, 2013
    Publication date: December 5, 2013
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Antara Banerjee, Paul G. Heyworth
  • MODULATION OF PILR RECEPTORS TO TREAT MICROBIAL INFECTIONS
    Publication number: 20120128673
    Abstract: The present invention provides methods of using agonists and antagonists of PILR? and PILR?, respectively, to treat S. aureus infection, in particular, S. aureus infections of the lungs. Also provided are use agonists and antagonists of PILR? and PILR?, respectively, to prevent such infections.
    Type: Application
    Filed: May 14, 2010
    Publication date: May 24, 2012
    Applicant: Schering Corporation
    Inventors: Antara Banerjee, Paul G. Heyworth
  • MODULATION OF PILR RECEPTORS TO TREAT SEPSIS
    Publication number: 20120121588
    Abstract: The present invention provides methods of using agonists and antagonists of PILR? and PILR?, respectively, to treat immune mediated sepsis. Also provided are methods of prophylactically treating with agonists and antagonists of PILR? and PILR? respectively, to prevent the development of sepsis.
    Type: Application
    Filed: May 14, 2010
    Publication date: May 17, 2012
    Applicant: SCHERING CORPORATION
    Inventors: Antara Banerjee, Paul G. Heyworth
  • Anti-MDL-1 antibodies
    Patent number: 8153134
    Abstract: Antibodies to human MDL-1 are provided, as well as uses thereof, e.g., in treatment of immune disorders, in particular, infectious diseases and sepsis.
    Type: Grant
    Filed: April 21, 2008
    Date of Patent: April 10, 2012
    Assignee: Schering Corporation
    Inventors: Michael E. Bigler, Paul G. Heyworth, Joseph H. Phillips, Leonard G. Presta
  • ANTI-MDL-1 ANTIBODIES
    Publication number: 20100150945
    Abstract: Antibodies to human MDL-1 are provided, as well as uses thereof, e.g., in treatment of immune disorders, in particular, infectious diseases and sepsis.
    Type: Application
    Filed: April 21, 2008
    Publication date: June 17, 2010
    Inventors: Michael E. Bigler, Paul G. Heyworth, Joseph H. Phillips, Leonard G. Presta